The costs of the government responses to the 2020 COVID-19 pandemic have been severe. New evidence suggests they could be even worse than we imagined.
An ABC affiliate in California reports that doctors at John Muir Medical Center tell them they have seen more deaths by suicide than COVID-19 during the quarantine.
As the concern for the coronavirus continues to grow, we want to do our part to inform our patients on what we are doing to help keep you safe and provide continued treatment options during this time.
Up to 80 percent of adults experience tension headaches throughout their lives — sharp throbbing pains that can occur throughout multiple regions in the head. Occasionally, people with depression experience headaches caused by their condition. Continue reading
Phantom limb pain, sometimes referred to as just phantom pain, is a form of chronic pain that feels as if it’s coming from a part of the body that is no longer there. Once believed to be simply a psychological phenomenon brought on after an amputation, but recent research proves that it is real pain originating from the brain and spinal cord. Continue reading
Complex Regional Pain Syndrome (CRPS) is a chronic neuro-inflammatory disorder that typically affects one specific limb after an injury, believed to be caused by damage to the nervous system. The pain is usually out of proportion when compared to the initial injury. Often, the initial energy is a musculoskeletal or nerve injury. Continue reading
Two new studies suggest the psychiatric benefits of ketamine treatment may extend beyond just the targeting of depression. The research demonstrates ketamine may be helpful in targeting both anxiety- and substance abuse-related depression. Continue reading
Intranasal ketamine is noninferior to intranasal fentanyl at relieving pain in children with acute extremity injuries, a new study found. Continue reading
People who get no depression relief from Prozac-type medicines have found a fast-acting substitute in a drug called ketamine. But is it safe? The National Institutes of Health has awarded a Florida State University researcher nearly $2 million to investigate ketamine, which some have called a wonder drug. Continue reading